 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Frontier Capital Management Co. LLC increased its stake in shares of Edwards Lifesciences Co. (NYSE:EW  Free Report) by 67.2% during the second quarter, according to its most recent disclosure...

Frontier Capital Management Co. LLC Buys 149,525 Shares of Edwards Lifesciences Co. (NYSE:EW)

Nuveen Asset Management LLC trimmed its holdings in Edwards Lifesciences Co. (NYSE:EW  Free Report) by 24.6% in the second quarter, according to its most recent disclosure with the Securities...

Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Nuveen Asset Management LLC

Prelude Capital Management LLC cut its stake in Edwards Lifesciences Co. (NYSE:EW  Free Report) by 35.0% in the second quarter, according to the company in its most recent disclosure with the...

Prelude Capital Management LLC Reduces Holdings in Edwards Lifesciences Co. (NYSE:EW)

Edwards Lifesciences (NYSE:EW  Get Free Report) and Altitude Acquisition (NASDAQ:ALTU  Get Free Report) are both medical companies, but which is the better business? We will compare the...

Edwards Lifesciences (NYSE:EW) & Altitude Acquisition (NASDAQ:ALTU) Financial Comparison

Baird Financial Group Inc. cut its stake in shares of Edwards Lifesciences Co. (NYSE:EW  Free Report) by 5.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...

Baird Financial Group Inc. Has $16.17 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)

StockNews.com upgraded shares of Edwards Lifesciences (NYSE:EW  Free Report) from a hold rating to a buy rating in a research note published on Monday. A number of other research firms have...

Edwards Lifesciences (NYSE:EW) Raised to Buy at StockNews.com

Epoch Investment Partners Inc. reduced its stake in Edwards Lifesciences Co. (NYSE:EW  Free Report) by 1.4% during the second quarter, according to the company in its most recent 13F filing...

Epoch Investment Partners Inc. Trims Stake in Edwards Lifesciences Co. (NYSE:EW)

Epoch Investment Partners Inc. trimmed its stake in Edwards Lifesciences Co. (NYSE:EW  Free Report) by 1.4% in the 2nd quarter, according to its most recent filing with the Securities and...

Epoch Investment Partners Inc. Sells 4,607 Shares of Edwards Lifesciences Co. (NYSE:EW)

J.P. Morgan analyst Robbie Marcus maintained a Buy rating on Edwards Lifesciences (EW Research Report) today. The company's shares closed yesterd...

Edwards Lifesciences (EW) Gets a Buy from J.P. Morgan

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Watchers	4,603
52-Wk Low	$60.57
52-Wk High	$94.87

Market Cap	$42.15B
Volume (M)	4.71M
52-Wk High	$94.87
52-Wk Low	$60.57

Period	Estimated	Reported	Surprise	Result
Q3'23	$0.59	$0.59	-0.47%	MISSED
Q2'23	$0.65	$0.66	1.89%	BEAT
Q1'23	$0.61	$0.62	1.90%	BEAT
Q4'22	$0.62	$0.64	3.89%	BEAT
Q3'22	$0.62	$0.61	-1.82%	MISSED

EW Edwards Lifesciences Corp

About

Feed

News

Sentiment

Earnings

Fundamentals